Simplicity Panels™ are PCR assays that are pre-pipetted into the PCR plate and provided in unique 96 well break-away plates for optimal price per result for your laboratory. Reduce reagent consumption and streamline assay set-up—select the number of panels needed and simply add your samples. Controlled reagent costs and improved workflow efficiencies lead to increases in lab profitability.
The Urinary Tract/ Wound Simplicity Panel™ is an in-vitro multiplex real-time polymerase chain reaction (RT-PCR) assay for the qualitative identification of nucleic acids from organisms frequently found in the urinary tract and wounds. This method is highly accurate, analytically sensitive, and is used to identify organisms by amplifying and detecting genetic material of pathogens in samples. The panel will aid in the research of causative agents of urinary tract and wound infections and their prevalence.
The target organisms included in the panel are as follows:
Acinetobacter baumannii, Bacteroides fragilis, Citrobacter freundii, Citrobacter koseri, Enterobacter cloacae, Enterococcus spp., Escherichia coli, Klebsiella aerogenes, Klebsiella oxytoca, Klebsiella pneumoniae, Morganella morganii, Proteus mirabilis, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, Staphylococcus epidemidis, Staphylococcus saprophyticus, and Streptococcus pyogenes (Group A).
Antibiotic Resistance Markers present are as follows: β-lactamase (blaKPC), β-lactamase (CTX-M-Group 1), metallo-β-lactamase (blaNDM), Fluoroquinolones (qnr), Methicillin/Oxacillin (mecA), Sulfonamides (sul), Trimethoprim (dfrA), and Vancomycin (vanA, vanB).
The Urinary Tract Panel is an in-vitro multiplex real-time polymerase chain reaction (RT-PCR) assay for the qualitative identification of nucleic acids from organisms frequently found in the urinary tract. This method is highly accurate, analytically sensitive and is used to identify organisms by amplifying and detecting genetic material of pathogens in samples. The panel will aid in the research of causative agents of urinary tract infections and their prevalence.
The target organisms included in the panel are as follows:
Acinetobacter baumannii, Bacteroides fragilis, Citrobacter braakii/ freundii, Citrobacter koseri, Enterobacter cloacae, Enterococcus spp., Escherichia coli, Klebsiella aerogenes, Klebsiella oxytoca / michiganensis, Klebsiella pneumoniae, Morganella morganii, Proteus mirabilis, Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus aureus, Staphylococcus epidemidis, Staphylococcus saprophyticus, Streptococcus pyogenes (Group A).
Antibiotic Resistance Markers present are as follows: β-lactamase (blaKPC), β-lactamase (CTX-M-Group 1), metallo-β-lactamase (blaNDM), Fluoroquinolones, Methicillin/Oxacillin (mecA), Sulfonamides, Trimethoprim, Vancomycin (vanA, van B).
*For Inquiries and Quote requests, please email CDxSupport@thomassci.com.
This content is hosted by a third party (youtube.com). To view external content you must agree to cookies.